Unicycive Therapeutics, Inc.

NASDAQ:UNCY

0.4347 (USD) • At close October 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -30.544-18.058-10.017-2.264-2.165-1.12
Depreciation & Amortization 0.2840.1610.013000
Deferred Income Tax -1.27600.127000
Stock Based Compensation 1.7671.0470.9660.2320.0240
Change In Working Capital -0.0931.178-0.105-0.1660.3050.006
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.2761.2671.241-0.0680.3080.031
Other Working Capital -1.369-0.089-1.346-0.098-0.003-0.025
Other Non Cash Items 11.5790.0213.2490.7390.660.308
Operating Cash Flow -18.283-15.651-5.767-1.459-1.176-0.775
Investing Activities:
Investments In Property Plant And Equipment -0.012-0.002-0.029000
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000000
Investing Cash Flow -0.012-0.002-0.029000
Financing Activities:
Debt Repayment 00-0.015-0.16-0.009-0.55
Common Stock Issued 28.0370.01122.390.1411.1660.25
Common Stock Repurchased 000000
Dividends Paid -0.86700000
Other Financing Activities 27.541-0.48222.3751.4630.0090.8
Financing Cash Flow 27.541-0.47122.3751.4441.1660.8
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 9.246-16.12416.579-0.015-0.010.025
Cash At End Of Period 9.7010.45516.57900.0150.025